Differential effects of haloperidol and clozapine on [3H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 1, 2002, Pages 197-209

  Dwivedi, Yogesh ^a   Rizavi, Hooriyah S ^a   Pandey, Ghanshyam N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CATALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; CYTOSOL; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ADENYLATE CYCLASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CLONING, MOLECULAR; CLOZAPINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSOL; HALOPERIDOL; ISOENZYMES; KINETICS; OLIGONUCLEOTIDE PROBES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, COMPLEMENTARY; RNA, MESSENGER;

EID: 0036193404     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.1.197     Document Type: Article

References (40)

1. Modulatory effect of clozapine on levodopa response in Parkinson's disease: A preliminary study
2. 1A receptor agonist properties of the antipsychotic, nemonapride: Comparison with bromerguride and clozapine
3. Do central antiadrenergic actions contribute to the atypical properties of clozapine?
4. Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells
5. Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia
6. Conventional antipsychotic medications for schizophrenia
7. Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase C (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain
8. 3H]cAMP binding to protein kinases A (PKA), cAMP-dependent PKA activity and protein levels of selective regulatory and catalytic subunit isoforms of PKA in rat brain
9. Modifications in the phosphoinositide signaling pathway by adrenal glucocorticoids in rat brain: Focus on phosphoinositide-specific phospholipase C and inositol 1,4,5-trisphosphate
10. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory
11. Effects of chronic treatment of haloperidol and clozapine on levels of G protein subunits in rat striatum
12. Actions of chlorpromazine, haloperidol and pimozide on lipid metabolism in guinea pig brain slices
13. Molecular cloning, cDNA structure, and regulation of the regulatory subunit of type II cAMP-dependent protein kinase from rat ovarian granulosa cells
14. Clozapine in treatment-resistant schizophrenics
15. Coadministration of progabide inhibits haloperidol-induced oral dyskinesias in rats
16. Effects of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo
17. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins
18. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase
19. 2c receptors in the rat choroid plexus after acute clozapine treatment
20. Chronic haloperidol treatment attenuates receptor-mediated phosphoinositide turnover in rat brain slices
21. Protein measurement with folin phenol reagent
22. A possible role of hippocampal dysfunction in schizophrenic symptomatology
23. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC
24. Chronic treatment with antipsychotic drugs does not alter G protein α or β subunit levels in rat brain
25. 1A receptors
26. Protein phosphorylation and the regulation of neuronal function
27. Clozapine in the treatment of tremor
28. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia
29. Update on the clinical efficacy of clozapine
30. The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain
31. Chronic haloperidol does not alter G protein α-subunit levels in rats
32. Abnormally high neuronal density in two widespread areas of the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17
33. Abnormalities of the left termporal lobe and thought disorder in schizophrenia
34. Changes in G protein levels in the hippocampus and the striatum of rat brain after chronic treatment with haloperidol and sulpiride
35. Molecular structure of the C beta catalytic subunit of rat cAMP-dependent protein kinase and differential expression of C alpha and C beta isoforms in rat tissues and cultured cells
36. Specificity in the cAMP/PKA signaling pathway, differential expression, regulation and subcellular localization of subunits of PKA
37. Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients
38. 2) receptors in the rat brain
39. 4 and receptor activation by some atypical antipsychotic drugs
40. 7 receptors in HeLa cells